Today, the American Diabetes Association and Medtronic together announced that we’re offering new research grants for diabetes technology. Essentially, we’re accepting applications from medical researchers to study the data from our CareLink- database to learn more about the impact of diabetes management tools on clinical outcomes, compliance and use of diabetes devices – as well as various factors that affect glycemic control in patients with diabetes.
Of course, those of you who use CareLink can rest assured that the data provided will be completely anonymous and HIPAA compliant.
This is a very exciting announcement for me. Those of you who attended the Medtronic Diabetes Advocate Forum in April may remember me talking about the wealth of data that CareLink holds and how much valuable information I think researchers would be able to pull out of it.
Medtronic made the CareLink Therapy Management Software for Diabetes available in 2004. After nearly seven years, we have information from more than 200,000 individuals, many with multiple years of data. I don’t know of anywhere else where the science community would be able to find this quantity of data. And I’m happy to be able to share it to give scientists the opportunity to better understand how patients manage their diabetes on a daily basis.
My hope is that the findings of this research will help healthcare providers like me better educate our patients. At the same time, I want industry to be able to learn from it so that when that next-generation product is underway, the engineers have insight that allows them to develop features that meet the needs of people with diabetes and further improves their lives.
If you (or someone you know) are a clinical or post doctoral fellow or scientist-in-training, I encourage you to apply at http://professional.diabetes.org.
Tags: American Diabetes Association